We investigated sexual function in female patients with coronary artery disease (CAD). A total of 20 consecutive female patients (38.273.8 years) with CAD diagnosed by coronary angiography and 15 healthy subjects (37.975.4 years) were enrolled in this study. The Female Sexual Function Index (FSFI) was used to assess sexual function in all the participants. Women with psychiatric disorders, gynecologic and systemic diseases that may affect sexual function were excluded from the study. The other exclusion criteria were usage of antidepressants and drugs affecting sexual function. Patients with CAD and healthy women were comparable in age, body mass index and education level. Female sexual dysfunction (FSD) was diagnosed in 12 of 20 women with CAD (60%), whereas five of 15 healthy women (33.3%) were found to have FSD (Po0.05). Patients with CAD had a significantly lower number of sexual intercourse episodes per month than healthy women volunteers (2.24 versus 5.2, respectively; Po0.05). The FSFI total score was clearly significantly decreased in the CAD group compared with that in healthy controls (17.872.9 and 26.074.8, P ¼ 0.001). When the subscores of each domain of FSFI were evaluated, all the subscores of FSFI, except the satisfaction domain, in patients with CAD were significantly lower than those of healthy subjects (Po0.05). This preliminary study demonstrates that female patients with CAD have distinct sexual dysfunction compared with healthy controls. Women with CAD should be evaluated also in terms of sexual function to provide better quality of life.
Introduction
Sexual function is a complex process coordinated by the neurological, vascular and endocrine systems. 1 Female sexual dysfunction (FSD) is age related, progressive and highly prevalent, affecting 22-76% of women according to age group. [2] [3] [4] [5] It has also been shown that sexual dysfunction (SD) was more prevalent among women (43%) than men (31%). FSD has a major impact on quality of life and interpersonal relationships. For many women, it has been physically disconcerting, emotionally distressing and socially disruptive. Women with FSD were found to have poorer quality of life, and it was recommended that the diagnosis and treatment of SD should be included in the clinical assessment of patients with chronic diseases. 6 Despite the high prevalence of FSD, little attention has been paid to the sexual problems of women. In contrast, there has been widespread interest in the research and treatment of male erectile dysfunction (ED). Fortunately, understanding the pathophysiology and the treatment modalities of male ED has resulted in studies geared to better understand and treat female sexual problems. 4 It is now widely accepted that ED in a substantial majority of men is due to underlying vascular causes, especially atherosclerosis. 7 Montorsi et al. 8 have shown that almost 50% of men with coronary artery disease (CAD) have ED, and 67% of men with CAD and ED reported ED symptoms that began before CAD symptoms. Recent studies including our previous paper concluded that ED and vascular disease may be linked at the level of the endothelium. 9, 10 Heightened interest and research studies in FSD have also brought new insight into cardiovascular changes. In addition, this research provides a better understanding of the endocrinological, neurological and genital changes in women with regard to their sexual response.
To our knowledge, there are very few studies related to sexual function assessment in women with CAD. Therefore, we investigated sexual function in women with demonstrated CAD.
Subjects and methods
Between June 2005 and February 2006, a total of 20 consecutive, sexually active, heterosexual women with a mean age of 38.273.8 years (range of 32-47) with CAD demonstrated by coronary angiography and 15 years age-matched, sexually active heterosexual healthy volunteer women without any cardiac symptoms from the female hospital staff (37.975.4 years; 28-46 years) were enrolled to participate in this investigation. The patients underwent dipyridamole myocardial contrast echocardiography (MCE) owing to stable angina pectoris, and in patients with myocardial perfusion defects, the anatomy of coronary vessels was analyzed by selective coronary angiography. In patients with significant coronary artery stenosis, the presence of 470% diameter narrowing of a coronary artery were included in the study. Severity of angina was estimated by Canadian Cardiovascular Society (CCS) classification of angina. All patients had CCS angina class 3 or 4. Healthy women as control group did not undergo coronary angiography to exclude any CAD. Patients and control women were recruited into the study after an informed consent was signed.
All the participants were evaluated by medical and sexual history. After a detailed physical examination, sexual function in these women was determined by the Female Sexual Function Index (FSFI), which was previously validated in the Turkish language. 11 The questionnaire, assessing sexual functioning with 19 questions, consists of six sexual domains; sexual desire (questions 1 and 2), arousal (questions 3-6), lubrication (questions 7-10), orgasm (questions 11-13), satisfaction (questions 14-16) and degree of pain (questions 17-19) during intercourse. 12 For each six domains, a score is calculated and the total score is obtained by adding the six domain scores. The total score range is 2-36. A total score of 425 is considered normal female sexual function and a total score o25 is considered SD.
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Blood was obtained to determine glucose, prolactin, luteinizing hormone (LH), dehydroepiandrosterone-SO (DHEA-SO), free testosterone (T), estradiol (E) and lipid profile in the follicular phase before 1000 h.
Women with psychiatric disorders including depression, gynecologic and systemic diseases that may affect sexual function were excluded from the study. The other exclusion criteria were diabetes, uncontrolled hypertension and smoking in the last 3 months in addition to the usage of antidepressants and drugs affecting sexual function.
Values were expressed as mean þ s.d. and data comparing the FSFI scores of patients with CAD to those of age-matched control group were analyzed using Mann-Whitney U-test. P-value less than 0.05 was considered significant. Calculations were made using SPSS software (SPSS, Chicago, IL, USA).
Results
Baseline demographics such as age, occupation, marital status, body mass index, fasting glucose and lipid levels as well as serum hormone profile were similar in patients with CAD and healthy women (P40.05) ( Table 1 ). There is no statistical difference between patients and healthy volunteers in case of usage of oral contraceptive drugs (12 in patients with CAD, 10 in healthy women; P40.05) and the average number of children of women in both groups (1.3 versus 1.2, respectively; P40.05).
Of the patients with CAD, six (30%) patients had hypertension as a risk factor. Coronary angiography results showed that nine (45%) had one-vessel disease, six (30%) had two-vessel disease and five (25%) had three-vessel disease. The average number of diseased vessel was found to be 1.8.
Patients with CAD had a significantly lower number of sexual intercourse episodes per month than healthy women volunteers (2.24 versus 5.2, respectively; Po0.05). FSD was diagnosed in 12 of 20 women with CAD (60%), whereas five of 15 healthy women (33.3%) were found to have FSD according to the FSFI score cutoff value of 25 (Po0.05). 11 The average FSFI total score was clearly significantly lower in the CAD group (17.872.9) than in healthy controls (26.074.8) (P ¼ 0.001).
When the scores of each domain of FSFI were evaluated, all the domain scores of FSFI, except the satisfaction domain, were significantly lower in the CAD group than those of healthy subjects (Po0.05). The domain scores for desire (P ¼ 0.01), arousal (P ¼ 0.004), lubrication (P ¼ 0.001), orgasm (P ¼ 0.000) and pain (P ¼ 0.05) were found to be statistically significantly decreased in women with CAD. The most affected domains were orgasm and lubrication. Although the satisfaction score was lower in patients with CAD, this difference was not found to be statistically significant ( Table 2) .
Discussion
Although FSD has a major impact on quality of life and interpersonal relationships, it has been less Sexual dysfunction in women with coronary artery disease C Kaya et al investigated than male ED. In recent years, some progress has been made in this field owing to heightened interest. 13 Evidence-based data indicated that ED is extremely common in men with CAD, 14 so that patients with CAD or risk factors should be asked about sexual health and ED. It was hypothesized that organic FSD may be related in part to vasculogenic impairment of the hypogastric-vaginal/clitoral arterial bed. The animal model of vaginal engorgement insufficiency showed that vaginal engorgement and clitoral erection depend on increased blood inflow. 15 To our knowledge, there are no studies about the status of the sexual function of women with CAD in the literature. Therefore, we chose to investigate the sexual function of patients with documented CAD by angiography. The data in our study revealed that FSD is more common in women with CAD (60%) than in healthy women (33%). All FSFI questionnaire domain scores were found to be affected with statistically significant differences in all domains except satisfaction. The average total FSFI score was also significantly lower in the CAD group than in healthy controls.
Several studies, researching the sexual function in women with chronic diseases, have reported that about 25% of healthy control women were found to have FSD. 16 In our study, 33% of healthy subjects had FSD, and this ratio was found to be comparable to the literature. Studies assessing FSD in cardiac patients are very rare. Tessier et al. 17 investigated the sexual function in women after elective aortic surgery and revealed that it is maintained in women undergoing open reconstructive aortic surgery. They found that women with occlusive disease tend to have poorer preoperative sexual function than aneurysm patients. Because of the association between SD and cardiovascular disease in both sexes, in addition to the potential cardiac risk of the sexual activity itself, a consensus panel developed some recommendations for the clinical management of SD in patients with cardiovascular disease. The panel concluded that patients should be stabilized by specific treatment for their cardiac condition before resuming sexual activity or being treated for SD. 18 In a study examining the prevalence and correlates of sexual activity and function in post-menopausal women with heart disease, 19 65% of women reported at least one of five sexual function problems. They recommended that physicians should be aware that post-menopausal women are sexually active and address the problems they experience. Endothelial dysfunction appears to be a common pathological etiology and mechanism of disease progression between CAD and ED, both sharing mutual vascular risk factors. Also, it is demonstrated that ED is an early symptom or harbinger of cardiovascular disease, owing to the Sexual dysfunction in women with coronary artery disease C Kaya et al common risk factors and pathophysiology mediated through endothelial dysfunction. 20 The present study revealed that two-thirds of women with proven CAD have FSD, which was considered comparable to the previous studies on SD and heart diseases.
The number of patients in our study was very small, so we limited our focus to simply compare the FSFI scores in women with CAD to healthy controls. We did not expand our investigation to include the other parameters relevant to FSD (age, hormonal status, marital status, education, previous sexual experience, parents' attitude toward sexual activity at various stages of life) and the association with the number of vessels involved in patients with CAD.
The first phase of female sexual function is desire, and it may be affected by psychological and emotional factors or it may be secondary to physical problems, such as hormone deficiencies and medical or surgical intervention. 13 Additionally, in women with CAD, desire level was found to be significantly lower. Arousal, the ability to attain or maintain sufficient sexual excitement, and vaginal lubrication, an indicator of genital sexual arousal and facilitator of sexual intercourse, were also found to be decreased significantly in our patients. Evidence obtained from basic science revealed that estrogens regulate the vascular components of genital tissues and androgens markedly facilitate genital blood flow and lubrication in estrogenized animals. 21 As genital blood flow is very important for lubrication and arousal, vascular diseases such as CAD are likely to result in the disturbances of these sexual cycle domains. Lubrication and orgasm were the most affected domains in our patients with CAD. The clitoris is the homolog of the penis with corpora responding to sexual excitement by tumescence and erection. The characteristics of clitoral blood flow increases parallely to those in males. Vaginal engorgement and clitoral erection depend on increased blood inflow, and atherosclerosis is associated with vaginal engorgement insufficiency and clitoral erectile insufficiency. 15 Additionally, pain score was also affected in patients group compared with healthy subjects. The only domain score that was not statistically significantly decreased was satisfaction level, although it was found to be relatively lower in CAD patients.
In conclusion, this study revealed that although the patient number is too small to draw conclusions, sexual function was significantly affected in women with CAD, and therefore should be evaluated in these patients. As there are not enough studies investigating female sexual function in vascular diseases, further studies with larger number of patients are necessary.
